newsfilter
← Latest News
GlobeNewswire·

Jounce Therapeutics to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that Jounce managem